Surowy, H., Schneeweiss, A., Bugert, P., Sohn, C., Bartram, C. R., Burwinkel, B., . . . Schott, S. (2014). Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance. Breast cancer research and treatment, 145(2), . https://doi.org/10.1007/s10549-014-2943-5
Chicago-Zitierstil (17. Ausg.)Surowy, Harald, et al. "Clinical and Molecular Characterization of the BRCA2 P.Asn3124Ile Variant Reveals Substantial Evidence for Pathogenic Significance." Breast Cancer Research and Treatment 145, no. 2 (2014). https://doi.org/10.1007/s10549-014-2943-5.
MLA-Zitierstil (9. Ausg.)Surowy, Harald, et al. "Clinical and Molecular Characterization of the BRCA2 P.Asn3124Ile Variant Reveals Substantial Evidence for Pathogenic Significance." Breast Cancer Research and Treatment, vol. 145, no. 2, 2014, https://doi.org/10.1007/s10549-014-2943-5.